I interview Drew McGregor, Vice President, Head of Medical Affairs Excellence & Sustainability at Bayer.

We discuss:

• How to balance patient focus with commercial objectives
• How to reduce silos across the organisation
• What would pharma look like without a separate MA strategy?

Interview with Sue Giordano - Head of Field Medical at Axsome Therapeutics.

We discuss:

• What types of data are available to medical affairs? 
• What is the first step when choosing the type of data to show impact (asking the right question)
• What else needs to be kept in mind (cross functional communication)
• Can you provide some examples of how data (and which type of data) can be used to show MA impact (MSLs and impact on diagnosis code examples - pilot it first before widespread roll out)
• What type of competencies need to be in place for MA to successfully utilize data to show their impact? 
• How can these competencies be developed (in house v external)

Carlos Eid from Novartis shares his expertise on:

The stakeholder engagement Journey

• Creating a seamless customer journey

• Starting with the patient
• Developing customer intimacy
• The types of data to collect along this engagement journey to assess if course correction is required.

I interview Raquel Washington, Executive Director Value Evidence Lead-Novartis US Medical.

Raquel shares her experience on:

- how Medical Science Liaisons (MSLs) can own their development

- the steps required to progress in their careers

- where to find those opportunities to grow and how to build relationships with those people in your network who will advocate for your growth.

Raquel has had an incredible career in pharma so far and shares specific examples from her own pharma career and some of the challenges she overcame to get to where she is today.

Free Newsletter on Medical Affairs Excellence: https://dynamic-salad-157.myflodesk.com/lbyatyklzm

Interview with Ross Baker, VP Medical Affairs at Vistagen Therapeutics.

I ask Ross:

• What your week looks like as a VP medical affairs for a small biotech?
• What are the different functions you work with?
• As a senior leader - how do you make decisions?
• What advice would you have for people listening who interact with senior leadership?
• Working as a VP for a company with many pipeline products and fast track designations, would require a lot of prioritization skills - how do you prioritize what you/your teams should be focusing on?

Siddharth Jain - Medical Director, Global Medical Lead, at Takeda Rare Diseases shares his experience in:

- What's the biggest difference from a medical affairs perspective working in rare diseases v non rare diseases?

- Is it more difficult to find and engage KOLs in rare diseases?

- What's the biggest challenge working in rare diseases from an MA perspective?

I Interview Scott Baver, VP Medical Affairs and we discuss building an MA department.

3 pillars in building an MA department:

• Community Engagement (HCPs/Payors) - who will we engage with & why?
• Evidence generation - over the lifecycle - what data do we need?
• Communication - pubs, building materials for congresses, MSLs etc.

MSL Consultant Newsletter: Sign up Here: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69

I interview Angelyn Solko and we discuss congress planning.

Specifically:

• What does congress planning involve?
• What do you need to keep in mind with booth design?
• Which stakeholders within pharma are involved in congress planning?
• Do you have to manage the budget?
• What is your role at the congress?
• What is your role post congress?
• What does a congress plan look like?

I interview Stacy Conner, National MSL Director at Abbvie.

We discuss:

• How MSLs can read the room when with KOLs
• Why it's important to disagree with KOLs
• The power of asking clarifying questions
• How to move KOLs to a place of understanding
• When to educate and when to gather insights




Sign up to the MSL Consultant newsletter here: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69

Marcus West from 60seconds shares his experience on how to develop the skill of storytelling and apply it to clinical data and KOL meetings.

We discuss:

• Important pillars of storytelling
• Why emotion is so important for engaging KOLs
• The hero's journey and how it can be related to clinical data

This episode is sponsored by 60seconds. Learn more about 60seconds here: https://60seconds.com/

MSL Interview? Book a 1:1 session here: https://mslconsultant.as.me/schedule.php

or view my online MSL interview course here: https://www.mslconsultant.com/msl-interview

In this interview I interview Dae Wook Lee from Novartis and we discuss:

5 Core components of Strategic Leader Framework:

I.        Build a strong foundation of scientific knowledge

II.      Develop a strategic mindset

III.     Focus on stakeholder engagement

IV.    Be a proactive problem solver

V. Embrace digital transformation

Enjoy the podcast? Please leave a 5 star rating or review on wherever you listen.

In this episode I interview Teresa G. Palumbo from GSK.

We discuss:

• Account planning
• Formulary
• RWE generation

💻New Resource for KOL Engagement: Read more here: https://mslconsultant.thrivecart.com/mastering-kol-engagement/ 💻

This episode covers:

• Leveraging your connections to get KOL meetings
• Adding value to KOLs
• Engaging lower tier KOLs
• Working with emerging experts

In this episode I interview Eleonora Goldberg, VP Medical Affairs.

We discuss:

-Difference between local, regional, global medical affairs roles

-Pre-Launch Medical Affairs Masterclass

• How to find KOLs
• How to choose an institute
• What it is?
• Follow up actions of MSLs post the masterclass
• The outcomes of this activity

Interested in 1:1 MSL Training? Click here: https://www.mslconsultant.com/msl-training1on1

Interview with Lori Lebson, Head of US medical Affairs at EMD Serono.

We discuss:

- Different stages of the product life cycle

- What an ISS is

- What "getting a label" means

- The role of an MSL at different stages

- Scientific storytelling and it's importance for MSLs to build relationships with KOLs

🔔Join my free newsletter and join over 3000 other medical affairs professionals getting insights on the MSL role 🔔 In this episode I interview Kirsten Gurtowsky MSL at Novartis.

We discuss:

• Differences of an medical science liaison working in big pharma versus small pharma
• Advantages of both

FREE Video Training for Aspiring MSL.

Enrol here.

https://www.mslconsultant.com/aspiringmsl

In this episode I share 4 tips to increase your chance of getting an MSL job.

⌛ Interested in 1:1 MSL Training? Click here: https://www.mslconsultant.com/msl-training1on1 ⌛

In this episode I interview Marieke Jonkman, emotional intelligence expert and we discuss:

- What is emotional intelligence

- How EI can improve an MSLs ability to improve patient outcomes

- How high EI could help an MSL navigate a KOL meeting that does not go as planned?

- How self-reflection can be used as a tool to increase EI for MSLs and specific questions MSLs could ask themselves post KOL interactions/every day/every week?

Interview with Max Ainscough.

We discuss:

• How MSLs can best collaborate with their commercial counterparts and demonstrate that they are a strategic partner as opposed to a support function.
• The best way to navigate internal politics with sales reps
• The specific actions MSLs can take to add more value at cross functional brand team meetings.

At the end of the episode Max summarises how an MSL can maximise their capabilities.

[➡️Join my free newsletter: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69]

Sacha and I discuss: 

• What is a patient journey partner
• How he does KOL pre-call planning
• The types of questions he asks his KOLs
• How to secure follow up meetings with KOLs and add value